BSE Circulars (20619)
Bombay Stock Exchange circulars covering trading rules, listing requirements, compliance guidelines, market operations, and regulatory changes for market participants.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE circular detailing the listing of new securities of Maan Aluminium Limited with lock-in expiry dates and distinctive number ranges for … | |||||||||||||||
BSE circular detailing the listing of new securities of Maan Aluminium Limited with lock-in expiry dates and distinctive number ranges for 59,00,000 shares.
| |||||||||||||||
BSE circular detailing the listing of new securities of Maan Aluminium Limited with lock-in expiry dates and distinctive numbers for … | |||||||||||||||
BSE circular detailing the listing of new securities of Maan Aluminium Limited with lock-in expiry dates and distinctive numbers for 59,00,000 shares.
| |||||||||||||||
BSE circular detailing the listing of new securities of MAAN ALUMINIUM LIMITED, including distinctive numbers, quantities, and lock-in … | |||||||||||||||
BSE circular detailing the listing of new securities of MAAN ALUMINIUM LIMITED, including distinctive numbers, quantities, and lock-in expiry dates for 59,00,000 shares.
| |||||||||||||||
BSE announces listing and trading permission for 4,00,000 new equity shares of Novelix Pharmaceuticals Limited (Scrip Code: 536565) … | |||||||||||||||
BSE announces listing and trading permission for 4,00,000 new equity shares of Novelix Pharmaceuticals Limited (Scrip Code: 536565) effective March 9, 2026, issued on a preferential basis pursuant to conversion of warrants.
| |||||||||||||||
BSE lists 4,00,000 new equity shares of Novelix Pharmaceuticals Limited issued on a preferential basis pursuant to conversion of warrants, … | |||||||||||||||
BSE lists 4,00,000 new equity shares of Novelix Pharmaceuticals Limited issued on a preferential basis pursuant to conversion of warrants, effective March 9, 2026.
| |||||||||||||||
BSE announces listing and trading permission for 4,00,000 new equity shares of Novelix Pharmaceuticals Limited effective March 9, 2026, … | |||||||||||||||
BSE announces listing and trading permission for 4,00,000 new equity shares of Novelix Pharmaceuticals Limited effective March 9, 2026, issued on a preferential basis pursuant to conversion of warrants.
| |||||||||||||||
BSE lists 4,00,000 new equity shares of Novelix Pharmaceuticals Limited (Scrip Code: 536565) for trading effective March 9, 2026, issued on … | |||||||||||||||
BSE lists 4,00,000 new equity shares of Novelix Pharmaceuticals Limited (Scrip Code: 536565) for trading effective March 9, 2026, issued on a preferential basis via conversion of warrants.
| |||||||||||||||
TVS Motor Company Limited has listed 6% Cumulative Non-Convertible Redeemable Preference Shares (NCRPS) on BSE and NSE, issued as bonus … | |||||||||||||||
TVS Motor Company Limited has listed 6% Cumulative Non-Convertible Redeemable Preference Shares (NCRPS) on BSE and NSE, issued as bonus shares aggregating to ₹1,900.35 crore.
| |||||||||||||||
BSE lists new commercial papers of DSP Finance, KEC International, Bajaj Finance, 360 ONE Alternates, ICICI Home Finance, and Capri Global … | |||||||||||||||
BSE lists new commercial papers of DSP Finance, KEC International, Bajaj Finance, 360 ONE Alternates, ICICI Home Finance, and Capri Global Capital on the debt market segment effective March 6, 2026.
| |||||||||||||||
BSE lists new privately placed commercial papers from DSP Finance, KEC International, Bajaj Finance, 360 ONE Alternates, ICICI Home Finance, … | |||||||||||||||
BSE lists new privately placed commercial papers from DSP Finance, KEC International, Bajaj Finance, 360 ONE Alternates, ICICI Home Finance, and Capri Global Capital on the debt market segment effective March 6, 2026.
| |||||||||||||||